Medicines Governance Team

Primary menu

Skip to primary content
Skip to secondary content
  • Home
  • About Us
  • Primary Care
    • Community Pharmacy Reporting Forms
      • Community Pharmacy Incidents/Near Misses
    • Controlled Drugs
      • Guidance
      • Letters
      • Private CDs
    • GP Practice
      • Prescription Security
      • Repeat/Acute Prescribing
    • High Risk Medicines
    • Medicines Safety Advice & Letters
    • Medicines Safety Audit & Guidelines
      • Audit
      • Guidelines
    • Newsletters
      • Medicines Safety Matters – Community Pharmacists
      • Medicines Safety Matters – Prescribers & Community Pharmacists
    • Posters & Leaflets
    • Presentations & Awards
      • Awards
      • Presentations
        • Posters
        • Training
  • Secondary Care
    • Medicines Safety Briefings
    • Newsletters
    • Safety Memos
    • Safety Documents
      • Guidelines
      • Policies
      • Recommendations
      • Safety Toolkits
        • Hyperkalaemia kit information
        • Omitted and Delayed Medicines Material
        • Regional Kardex Templates
    • Publications & Awards
      • Awards
      • Journal publications
      • Oral presentations
      • Poster presentations
  • Primary/Secondary Care
    • Medicines Safety Documents
      • Anticoagulants
      • Insulin
      • Lithium
      • Opioids
  • Contact Us
  • Accountable Officer
    • Accountable Officer Training
    • Annual Report
    • Forms
    • Guidance
    • Legislation
    • Local Intelligence Network (LIN)

Safety Memos

Document NameDateFile Description
Safety memo 01 - Pneumovax Feb 2002
Safety Memo 01 - Pneumovax Jan 2016
Safety Memo 02 - Vancomycin Oct 2002
Safety Memo 03 - Dexamethasone Jun 2003
Safety Memo 04 - Phenytoin Aug 2003
Safety Memo 04 - Update 21 Feb 07 Feb 2007
Safety Memo 05 - BAN To RINN Apr 2004
Safety Memo 06 - Enoxaparin Jun 2004
Safety Memo 07 - Priadel Sep 2004
Safety Memo 08 - Ciprofloxacin Apr 2005
Safety Memo 09 - Medication Syringes Aug 2005
Safety Memo 10 - Konakion Mar 2006
Safety Memo 11 - High Dose Opiate Ampoules Aug 2006
Safety Memo 12 - Slow K And Slow Sodium Jul 2007
Safety Memo 13 - Revised Additive Labels Jul 2009
Safety Memo 14 B Dexamethasone Jul 2010
Safety Memo 15 - IV Paracetamol Jun 2011
Safety Memo 16 - Buccal Midazolam Apr 2012
Safety Memo 17 Opioid transdermal patches Sep 2012
©2014 - Medicines Governance Northern Ireland
Manage Cookie Consent
close
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage third parties Manage vendors Read more about these purposes
View preferences
{title} {title} {title}